BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 35288462)

  • 21. Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma.
    Reschke R; Yu J; Flood B; Higgs EF; Hatogai K; Gajewski TF
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.
    Richard G; Dalle S; Monet MA; Ligier M; Boespflug A; Pommier RM; de la Fouchardière A; Perier-Muzet M; Depaepe L; Barnault R; Tondeur G; Ansieau S; Thomas E; Bertolotto C; Ballotti R; Mourah S; Battistella M; Lebbé C; Thomas L; Puisieux A; Caramel J
    EMBO Mol Med; 2016 Oct; 8(10):1143-1161. PubMed ID: 27596438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy.
    Lu C; Klement JD; Smith AD; Yang D; Waller JL; Browning DD; Munn DH; Liu K
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33051343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma.
    Trujillo JA; Luke JJ; Zha Y; Segal JP; Ritterhouse LL; Spranger S; Matijevich K; Gajewski TF
    J Immunother Cancer; 2019 Nov; 7(1):295. PubMed ID: 31703593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
    Wu HT; Zhong HT; Li GW; Shen JX; Ye QQ; Zhang ML; Liu J
    J Transl Med; 2020 Feb; 18(1):51. PubMed ID: 32014049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of EMT Factor ZEB1 in cDC1 "MutuDC Line" Mediated Induction of Th1 Immune Response.
    Smita S; Ahad A; Ghosh A; Biswas VK; Koga MM; Gupta B; Acha-Orbea H; Raghav SK
    Front Immunol; 2018; 9():2604. PubMed ID: 30483264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.
    Canè S; Van Snick J; Uyttenhove C; Pilotte L; Van den Eynde BJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An IFNγ/STAT1/JMJD3 Axis Induces ZEB1 Expression and Promotes Aggressiveness in Lung Adenocarcinoma.
    Yang J; Wang X; Huang B; Liu R; Xiong H; Ye F; Zeng C; Fu X; Li L
    Mol Cancer Res; 2021 Jul; 19(7):1234-1246. PubMed ID: 33771881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
    Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
    Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiopoietin-2-Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma.
    Park HR; Shiva A; Cummings P; Kim S; Kim S; Lee E; Leong A; Chowdhury S; Shawber C; Carvajal R; Thurston G; An JY; Lund AW; Yang HW; Kim M
    Cancer Res; 2023 Jun; 83(12):1968-1983. PubMed ID: 37093870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
    Wu R; Wang C; Li Z; Xiao J; Li C; Wang X; Kong P; Cao J; Huang F; Li Z; Huang Y; Chen Y; Li X; Yang D; Zhang H; Mai J; Feng G; Deng R; Zhu X
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33158915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway.
    Zheng X; Luo Y; Xiong Y; Liu X; Zeng C; Lu X; Wang X; Cheng Y; Wang S; Lan H; Wang K; Weng Z; Bi W; Gan X; Jia X; Wang L; Wang Y
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells.
    Guo Y; Lu X; Chen Y; Rendon B; Mitchell RA; Cuatrecasas M; Cortés M; Postigo A; Liu Y; Dean DC
    Sci Adv; 2021 May; 7(21):. PubMed ID: 34020945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
    Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
    Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
    J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.
    Stirling ER; Terabe M; Wilson AS; Kooshki M; Yamaleyeva LM; Alexander-Miller MA; Zhang W; Miller LD; Triozzi PL; Soto-Pantoja DR
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36418073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
    Larsen JE; Nathan V; Osborne JK; Farrow RK; Deb D; Sullivan JP; Dospoy PD; Augustyn A; Hight SK; Sato M; Girard L; Behrens C; Wistuba II; Gazdar AF; Hayward NK; Minna JD
    J Clin Invest; 2016 Sep; 126(9):3219-35. PubMed ID: 27500490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
    Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
    J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZEB and Snail expression indicates epithelial-mesenchymal transition in canine melanoma.
    Veloso ES; Gonçalves INN; Silveira TL; Espirito Santo JT; Figueiredo LV; Varaschin MS; Cassali GD; Del Puerto HL; Ferreira E
    Res Vet Sci; 2020 Aug; 131():7-14. PubMed ID: 32278962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.